Royal Bank Of Canada Johnson & Johnson Call Options Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $756,496 - $870,376	-5,200 Reduced 24.07%	16,400 $2.66 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $952,908 - $1.04 Million	6,600 Added 44.0%	21,600 $3.16 Million
Q1 2024 Nov 05, 2024	SELL	$155.22 - $162.74 $1.02 Million - $1.07 Million	-6,600 Reduced 30.56%	15,000 $2.37 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $6.98 Million - $7.32 Million	-45,000 Reduced 75.0%	15,000 $2.37 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $7.01 Million - $7.85 Million	45,000 Added 300.0%	60,000 $9.35 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $2.32 Million - $2.49 Million	15,000 New	15,000 $2.48 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $5.61 Million - $6.29 Million	35,000 New	35,000 $6.18 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $73.9 Million - $83.9 Million	467,300 Added 88.79%	993,600 $176 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $82.1 Million - $91.1 Million	526,300 New	526,300 $90 Million

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.